Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|June 19, 2022
Impact of FGFR2 gene fusions on survival of patients with intrahepatic cholangiocarcinoma following curative intent resectionEeeLN Buckarma, Gabriel De La Cruz, Mark Truty, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|February 25, 2017
A longitudinal study of whole body, tissue, and cellular physiology in a mouse model of fibrosing NASH with high fidelity to the human conditionAnuradha Krishnan, Tasduq Sheikh Abdullah, Taofic Mounajjed, et al.
Cancer Detection and Prevention|November 16, 2004
Clinicopathological correlates of aspartyl (asparaginyl) beta-hydroxylase over-expression in cholangiocarcinomaTakashi Maeda, Ken-ichi Taguchi, Shin-ichi Aishima, et al.
Oncotarget|September 9, 2017
Metformin requires 4E-BPs to induce apoptosis and repress translation of Mcl-1 in hepatocellular carcinoma cellsMamatha Bhat, Akiko Yanagiya, Tyson Graber, et al.
Plos One|September 27, 2013
Role for Krüppel-like transcription factor 11 in mesenchymal cell function and fibrosisAngela Mathison, Adrienne Grzenda, Gwen Lomberk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2010
Hepatocellular carcinoma: consensus recommendations of the National Cancer Institute Clinical Trials Planning MeetingMelanie B Thomas, Deborah Jaffe, Michael M Choti, et al.
Investigational New Drugs|August 31, 2021
A pilot study of Pan-FGFR inhibitor ponatinib in patients with FGFR-altered advanced cholangiocarcinomaDaniel H Ahn, Pedro Luiz Serrano Uson Junior, Peter Masci, et al.
The American Journal of Gastroenterology|September 23, 2003
Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic statusAdrian M Di Bisceglie, Andre C Lyra, Myron Schwartz, et al.
JCO Precision Oncology|November 15, 2021
FGFR Inhibitor Toxicity and Efficacy in Cholangiocarcinoma: Multicenter Single-Institution Cohort ExperienceJennifer J Gile, Fang-Shu Ou, Amit Mahipal, et al.
Journal of Hepatology|December 4, 2020
CD40-mediated immune cell activation enhances response to anti-PD-1 in murine intrahepatic cholangiocarcinomaLaurence P Diggs, Benjamin Ruf, Chi Ma, et al.
Pageof 3